Surge in Put Option Activity for Sun Pharmaceutical with 9,437 Contracts Traded at Rs 1,700

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The underlying stock, SUNPHARMA, has seen significant activity with 9,437 contracts traded, reflecting a turnover of approximately Rs 531.11 lakhs. The put options have a strike price of Rs 1,700 and are set to expire on July 31, 2025. Open interest stands at 2,534 contracts, indicating ongoing interest in this option.
In terms of price performance, SUNPHARMA is currently valued at Rs 1,729. The stock's performance today aligns with the sector, showing a modest one-day return of 0.14%, while the sector itself reported a return of 0.02%. Notably, the stock has experienced a trend reversal, having fallen after three consecutive days of gains. It has traded within a narrow range of Rs 13.3, and its current price is above the 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.

Investor participation has risen, with a delivery volume of 17.17 lakhs on July 15, marking a 57.52% increase compared to the 5-day average. The stock's liquidity is also favorable, accommodating trade sizes of Rs 6.89 crores based on 2% of the 5-day average traded value. Overall, Sun Pharmaceutical Industries Ltd continues to attract attention in the market, reflecting its significant position within the pharmaceuticals and biotechnology industry.